Randy Ban - 01 Mar 2023 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role: Chief Commercial Officer
Signature: /s/ Bryan Phillips, as Attorney-in-Fact for Randy Ban
Issuer symbol: INSP
Transactions as of: 01 Mar 2023
Net transactions value: -$83,521,691
Form type: 4
Filing time: 03 Mar 2023, 15:06:23 UTC
Previous filing: 14 Feb 2023
Next filing: 13 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INSP	Common Stock	Options Exercise	$9,400	+10,000	+3289%	$0.9400^*	10,304	01 Mar 2023	Direct
transaction	INSP	Common Stock	Sale	$304,396	-1,177	-11%	$258.62	9,127	01 Mar 2023	Direct	F1, F2, F3
transaction	INSP	Common Stock	Sale	$836,882	-3,222	-35%	$259.74	5,905	01 Mar 2023	Direct	F1, F3, F4
transaction	INSP	Common Stock	Sale	$81,741,990	-3,135	-53%	$26074.00^*	2,770	01 Mar 2023	Direct	F1, F3, F5
transaction	INSP	Common Stock	Sale	$235,386	-900	-32%	$261.54	1,870	01 Mar 2023	Direct	F1, F3, F6
transaction	INSP	Common Stock	Sale	$412,437	-1,566	-84%	$263.37	304	01 Mar 2023	Direct	F1, F3, F7
holding	INSP	Common Stock						167	01 Mar 2023	By son
holding	INSP	Common Stock						166	01 Mar 2023	By daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INSP	Stock Option (Right to Buy)	Options Exercise	$0	-10,000	-47%	$0.000000	11,090	01 Mar 2023	Common Stock	10,000	$0.9400	Direct	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.13 to $259.09, inclusive.
F3	The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.23 to $260.12, inclusive.
F5	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.24 to $261.20, inclusive.
F6	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.27 to $262.06, inclusive.
F7	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.88 to $263.69, inclusive.
F8	The option is fully vested and exercisable.